Skip to content
Clinical Trials – home
CroatiaBack to Croatia

Clinical trials in Bjelovar

4 clinical trials in Bjelovar, Croatia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CroatiaOur site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)
Bjelovar at a glance
4
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

4 trials in Bjelovar

Open in trial search
Investigational
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Alvotech Swiss AG
Registered drug
Countries:CroatiaCroatia
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:Janssen - Cilag International

Other cities in Croatia

The busiest research cities in the country

All 26 cities in Croatia

Clinical research in Bjelovar

What the registry says about research in the country

01 Inflammatory Bowel Disease Research

Innovative clinical trials focusing on Ulcerative Colitis treatments, evaluating new therapeutic approaches for patients with moderate to severe symptoms. Studies are comparing novel biologics and investigating combination therapies to enhance treatment outcomes.

  • Novel biologic therapies
  • Treatment combinations
  • Biosimilar evaluations

Multiple trials are exploring both established and experimental medications to improve remission rates.

02 Crohn's Disease Studies

Groundbreaking research examining subcutaneous treatment options for patients with moderately to severely active Crohn's Disease. Clinical investigations are focused on measuring both clinical remission and endoscopic response.

  • Induction therapy effectiveness
  • Disease management strategies
  • Clinical remission rates

These studies aim to expand treatment options for patients with inflammatory bowel conditions.

03 Stroke Prevention and Treatment

Critical research into preventing recurrent ischemic stroke and managing high-risk transient ischemic attacks. Studies are evaluating new preventive medications to reduce stroke risk in vulnerable patients.

  • Acute stroke management
  • Prevention strategies
  • Risk reduction therapies

These trials represent significant advances in stroke prevention and treatment protocols.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.